Urinary C5b-9 as a Prognostic Marker in IgA Nephropathy

Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys

(2021) Jacob J. E. Koopman et al.   Frontiers in Immunology

Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression

(2021) Brendon L. Neuen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis

(2021) Lesley A. Inker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Using GFR, Albuminuria, and Their Changes in Clinical Trials and Clinical Care

(2021) Josef Coresh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura

(2020) Camille Dumont et al.   PEDIATRIC NEPHROLOGY

Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis

(2019) Hannah R. Wilson et al.   KIDNEY INTERNATIONAL

C3 glomerulopathy — understanding a rare complement-driven renal disease

(2019) Richard J. H. Smith et al.   Nature Reviews Nephrology

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

(2019) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers

(2019) Byung Chul Yu et al.   Scientific Reports

IgA nephropathy: new insights into the role of complement

(2018) Jürgen Floege et al.   KIDNEY INTERNATIONAL

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

(2017) Hernán Trimarchi et al.   KIDNEY INTERNATIONAL

Markers for the progression of IgA nephropathy

(2016) Dita Maixnerova et al.   JOURNAL OF NEPHROLOGY

The MEST score provides earlier risk prediction in lgA nephropathy

(2016) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

Current Understanding of the Role of Complement in IgA Nephropathy

(2015) N. Maillard et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy

(2015) Riccardo Magistroni et al.   KIDNEY INTERNATIONAL

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis

(2013) Laurence Beck et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy

(2012) L.-L. Liu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

An update on the pathogenesis and treatment of IgA nephropathy

(2012) Joanna K. Boyd et al.   KIDNEY INTERNATIONAL

High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy

(2011) H. P. E. Peters et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function

(2011) Kisara Onda et al.   BMC Nephrology

Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study

(2010) H. TAMAI et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies

(2010) Khalil El Karoui et al.   KIDNEY INTERNATIONAL

Comments on the Oxford classification of IgA nephropathy

(2009) Gary S. Hill et al.   KIDNEY INTERNATIONAL

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

(2009) Daniel C. Cattran et al.   KIDNEY INTERNATIONAL